Skip to content
DraconiticResearch
Search Sources API
220,595 studies31 sourcesUpdated 45 min ago

Oncology

5,778 studies502 in 7 days2,682 in 30 days

Filters
Type
Date
Clear

Latest

5,778 studies

  1. Incidental detection of cancers during population-based endoscopic gastric cancer screening in Japan
    Kensuke Uraguchi, Kenta Hamada, Naomi Matsumoto +5
    EsophagusPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness
    Marianne Guilbard, Saïd Taouji, Marc Aubry +15
    OncogenePeer-reviewedCC BY 4.0Full textOncologyHAL
  3. Quinoxalinone‐based, endoplasmic reticulum‐targeting photosensitizer nanoparticles for tumor photodynamic therapy
    Chao Sun, Lici Wang, Tao Li +3
    Bioengineering & Translational MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Self-Supervised AI Discovery of Histomorphological Phenotypes from Routine Mesothelioma Biopsies
    F. A. Seyedshahi, F. Damiola, R. Sequeiros +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma
    Karam Ashouri, Fan Sun, Harris Krause +8
    British Journal of CancerPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  6. Translational analysis of miRNA–mRNA regulatory networks in male rat and human prefrontal cortex following chronic opioid self-administration
    Timea Raffai, Leila Saikali, Gabriele Floris +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  7. Comparative analysis of the CT and MRI features of pancreatic colloid carcinoma
    Qingyang Wu, Mingliang Wang, Shasha He +3
    Diagnostic PathologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  8. Loss of Farnesoid X Receptor promotes colorectal liver metastasis via the GutFXR–FGF15–PPARγ–VEGFα–MDSC axis
    Yan Chen, Yufei Wu, Yu Yang +3
    Molecular MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  9. Efficacy of anti-PD-1/PD-L1 plus chemotherapy in treatment-naïve advanced HER2-negative gastric adenocarcinoma among different PD-L1 intervals: an updated meta-analysis and reconstructed individual patient-level data analysis
    Yu-Kun Chen, Wen-Wei Wu, Fan Chen +6
    BMC MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Expression, association with clinicopathological features and prognostic potential of FOXR2, mTOR, HIF−1α and PKM2 in high−grade serous carcinoma of the ovary
    Lianguo Hou, Xinyi Dong, Min Li +4
    Diagnostic PathologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  11. Current Role of Endoscopic Ultrasonography in the Early Detection of Pancreatic Cancer: Recognition of Indirect Imaging Findings and Diagnostic Strategy
    Keiji Hanada
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  12. Twisted Peribronchovascular Consolidation in Pembrolizumab-induced Pneumonitis
    Hideaki Yamakawa, Chisa Uzuka, Akiko Adachi +1
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  13. Diffuse Leptomeningeal Glioneuronal Tumor With Peritoneal Seeding After Ventriculoperitoneal Shunt in an Adult Patient: A Case Report
    Chaejin Lee, Ki-Su Park, Seong-Hyun Park +2
    Brain Tumor Research and TreatmentPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  14. DLGAP1-AS2 knockdown increases chemosensitivity to vandetanib and synergistically inhibits metastatic activity of papillary thyroid cancer cells: experimental and computational approaches
    Saeedeh Saderi Oskuie, Seyedeh Zahra Bahojb Mahdavi, Abbas Nikravesh +5
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  15. A functional landscape for chromosome 17q in neuroblastoma: balancing replication stress and genomic stability
    Elien Hilgert, Lisa Depestel, Nadine Van Roy +3
    British Journal of CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  16. Prognostic value of lymphocyte to monocyte ratio for metastatic renal cell carcinoma: a systematic review and meta-analysis
    Xingbao Zhang, Yao Wu, Zhongyi Zeng
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  17. Palbociclib and rapamycin pretreatment boosted the persistence and functionality of CAR-T cells in solid tumors through metabolic reprogramming
    Muya Zhou, Lianfeng Zhao, Zhiying Chen +12
    Journal of Translational MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  18. Targeting oxidative phosphorylation with lixumistat overcomes PARP inhibitor resistance in ovarian cancer
    Sa Deok Hong, Nar Bahadur Katuwal, Mithun Ghosh +5
    Cell Death & DiseasePeer-reviewedCC BY 4.0Full textOncologyPMC
  19. Anorectal manometry after rectal cancer surgery: physiological insights, clinical interpretation, and limitations
    K. L. Park, D. K. Sohn
    Techniques in ColoproctologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  20. Introduction of robot-assisted double-flap esophagogastrostomy after proximal gastrectomy: an exploratory comparison with side-overlap reconstruction
    Naoto Takahashi, Shigeaki Baba, Haruka Nikai +5
    Langenbeck's Archives of SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  21. Prognostic value of the inflammatory prognostic index for postoperative recurrence in non-muscle-invasive bladder cancer
    GengXu Li, Chao Tan, JunLi Wei +1
    BMC UrologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  22. Factors associated with bowel cancer screening participation among First Nations Peoples receiving home health care services in New South Wales, Australia
    Tsegaw Amare Baykeda, Shafkat Jahan, Kirsten Howard +10
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  23. Clinical impact of second radiotracer injection after failed lymphoscintigraphy in breast cancer sentinel lymph node biopsy: a retrospective cohort study
    Leo Hänninen, Riitta I Aaltonen, Eeva Juhanoja +1
    World Journal of Surgical OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. RPPH1 drives ovarian cancer cells proliferation via CDK9-c-Myc axis
    Yue Chen, Li Tang, Haodong Huang +4
    Journal of Ovarian ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  25. The predictive value of PD-1 for the response to immune checkpoint inhibitor therapy in patients with bladder cancer without lymph node metastasis and its association with survival outcomes
    Wei Zheng, Cenchao Yao, Zhida Wang +1
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC